MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zang, M.
Right arrow Articles by Miller, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zang, M.
Right arrow Articles by Miller, L. J.

Vol. 63, Issue 5, 993-1001, May 2003

Spatial Approximation between a Photolabile Residue in Position 13 of Secretin and the Amino Terminus of the Secretin Receptor

Mengwei Zang, Maoqing Dong, Delia I. Pinon, Xi-Qin Ding, Elizabeth M. Hadac, Zhijun Li, Terry P. Lybrand, and Laurence J. Miller

Cancer Center and the Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Scottsdale, Scottsdale, Arizona (M.Z., M.D., D.I.P., X.-Q.D., E.M.H., L.J.M.); and Department of Chemistry and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee (Z.L., T.P.L.)

The amino-terminal domain of class B G protein-coupled receptors is critically important for natural peptide agonist binding and action. The precise role it plays and the molecular basis of the interaction between ligand and this domain are not well understood. In the current work, we have developed a new probe for affinity labeling the secretin receptor through a photolabile benzoyl-phenylalanine residue in position 13. This represented a high affinity ligand (Ki = 56 ± 8 nM) that was a potent full agonist to stimulate cellular cAMP (EC50 = 236 ± 22 pM). It covalently labeled the secretin receptor saturably in a single site. This was localized to the amino-terminal domain near the first transmembrane segment using a series of chemical and enzymatic digestions. Edman degradation sequencing of radiolabeled cyanogen bromide and skatole digestion products that were attached to glass beads and further cleaved with endoproteinase Asp-N demonstrated that the labeled residue represented Val103. This is in contrast with previous photoaffinity labeling through positions 6, 18, 22, and 26 of secretin that all labeled the distal end of the amino terminus of this receptor. Together, these five pairs of residue-residue approximations provide important constraints to better understand the molecular conformation of the agonist-bound receptor.


Copyright © 2003 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
M. Dong, P. C.-H. Lam, D. I. Pinon, P. M. Sexton, R. Abagyan, and L. J. Miller
Spatial Approximation between Secretin Residue Five and the Third Extracellular Loop of Its Receptor Provides New Insight into the Molecular Basis of Natural Agonist Binding
Mol. Pharmacol., August 1, 2008; 74(2): 413 - 422.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Hou, S. Xu, K. A. Maitland-Toolan, K. Sato, B. Jiang, Y. Ido, F. Lan, K. Walsh, M. Wierzbicki, T. J. Verbeuren, et al.
SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase
J. Biol. Chem., July 18, 2008; 283(29): 20015 - 20026.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. G. Harikumar, D. I. Pinon, and L. J. Miller
Transmembrane Segment IV Contributes a Functionally Important Interface for Oligomerization of the Class II G Protein-coupled Secretin Receptor
J. Biol. Chem., October 19, 2007; 282(42): 30363 - 30372.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. S. Lisenbee, K. G. Harikumar, and L. J. Miller
Mapping the Architecture of Secretin Receptors with Intramolecular Fluorescence Resonance Energy Transfer Using Acousto-Optic Tunable Filter-Based Spectral Imaging
Mol. Endocrinol., August 1, 2007; 21(8): 1997 - 2008.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Dong, P. C.-H. Lam, F. Gao, K. Hosohata, D. I. Pinon, P. M. Sexton, R. Abagyan, and L. J. Miller
Molecular Approximations between Residues 21 and 23 of Secretin and Its Receptor: Development of a Model for Peptide Docking with the Amino Terminus of the Secretin Receptor
Mol. Pharmacol., August 1, 2007; 72(2): 280 - 290.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Dong, K. Hosohata, D. I. Pinon, N. Muthukumaraswamy, and L. J. Miller
Differential Spatial Approximation between Secretin and Its Receptor Residues in Active and Inactive Conformations Demonstrated by Photoaffinity Labeling
Mol. Endocrinol., July 1, 2006; 20(7): 1688 - 1698.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Dong, D. I. Pinon, Y. W. Asmann, and L. J. Miller
Possible Endogenous Agonist Mechanism for the Activation of Secretin Family G Protein-Coupled Receptors
Mol. Pharmacol., July 1, 2006; 70(1): 206 - 213.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. G. Harikumar, K. Hosohata, D. I. Pinon, and L. J. Miller
Use of Probes with Fluorescence Indicator Distributed throughout the Pharmacophore to Examine the Peptide Agonist-binding Environment of the Family B G Protein-coupled Secretin Receptor
J. Biol. Chem., February 3, 2006; 281(5): 2543 - 2550.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Dong, D. I. Pinon, and L. J. Miller
Insights into the Structure and Molecular Basis of Ligand Docking to the G Protein-Coupled Secretin Receptor Using Charge-Modified Amino-Terminal Agonist Probes
Mol. Endocrinol., July 1, 2005; 19(7): 1821 - 1836.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. S. Lisenbee, M. Dong, and L. J. Miller
Paired Cysteine Mutagenesis to Establish the Pattern of Disulfide Bonds in the Functional Intact Secretin Receptor
J. Biol. Chem., April 1, 2005; 280(13): 12330 - 12338.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Dong, D. I. Pinon, R. F. Cox, and L. J. Miller
Molecular Approximation between a Residue in the Amino-terminal Region of Calcitonin and the Third Extracellular Loop of the Class B G Protein-coupled Calcitonin Receptor
J. Biol. Chem., July 23, 2004; 279(30): 31177 - 31182.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Pham, J. D. Wade, B. W. Purdue, and P. M. Sexton
Spatial Proximity between a Photolabile Residue in Position 19 of Salmon Calcitonin and the Amino Terminus of the Human Calcitonin Receptor
J. Biol. Chem., February 20, 2004; 279(8): 6720 - 6729.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Dong, Z. Li, D. I. Pinon, T. P. Lybrand, and L. J. Miller
Spatial Approximation between the Amino Terminus of a Peptide Agonist and the Top of the Sixth Transmembrane Segment of the Secretin Receptor
J. Biol. Chem., January 23, 2004; 279(4): 2894 - 2903.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Dong, D. I. Pinon, R. F. Cox, and L. J. Miller
Importance of the Amino Terminus in Secretin Family G Protein-coupled Receptors: INTRINSIC PHOTOAFFINITY LABELING ESTABLISHES INITIAL DOCKING CONSTRAINTS FOR THE CALCITONIN RECEPTOR
J. Biol. Chem., January 9, 2004; 279(2): 1167 - 1175.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Dong, Z. Li, M. Zang, D. I. Pinon, T. P. Lybrand, and L. J. Miller
Spatial Approximation between Two Residues in the Mid-region of Secretin and the Amino Terminus of Its Receptor: INCORPORATION OF SEVEN SETS OF SUCH CONSTRAINTS INTO A THREE-DIMENSIONAL MODEL OF THE AGONIST-BOUND SECRETIN RECEPTOR
J. Biol. Chem., November 28, 2003; 278(48): 48300 - 48312.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics